EC Number   |
Disease |
PubMed ID  |
Title of Publication |
Category |
Confidence Level |
|---|
    2.5.1.21 | Carcinoma, Hepatocellular |
1318747 |
Subcellular localization of squalene synthase in human hepatoma cell line Hep G2. |
ongoing research
unassigned |
4
0 |
| 2.5.1.21 | Neoplasms |
1806189 |
[Farnesyltransferase as target for non-cytotoxic anti-cancer agents: first steps] |
causal interaction
therapeutic application
unassigned |
1
3
0 |
| 2.5.1.21 | Myocardial Infarction |
2280101 |
[Evaluation of ventricular arrhythmias late after coronary artery bypass graft surgery--relation to clinical variables] |
therapeutic application
unassigned |
1
0 |
| 2.5.1.21 | Carcinoma, Hepatocellular |
2538145 |
Regulation of squalene synthetase in human hepatoma cell line Hep G2 by sterols, and not by mevalonate-derived non-sterols. |
ongoing research
unassigned |
2
0 |
| 2.5.1.21 | Lung Neoplasms |
3610444 |
Correlation between high salt intake and mortality rates for oesophageal and gastric cancers in Henan Province, China. |
diagnostic usage
unassigned |
1
0 |
| 2.5.1.21 | Neoplasms |
3610444 |
Correlation between high salt intake and mortality rates for oesophageal and gastric cancers in Henan Province, China. |
diagnostic usage
unassigned |
1
0 |
| 2.5.1.21 | Stomach Neoplasms |
3610444 |
Correlation between high salt intake and mortality rates for oesophageal and gastric cancers in Henan Province, China. |
diagnostic usage
unassigned |
1
0 |
| 2.5.1.21 | Uterine Cervical Neoplasms |
3610444 |
Correlation between high salt intake and mortality rates for oesophageal and gastric cancers in Henan Province, China. |
diagnostic usage
unassigned |
1
0 |
| 2.5.1.21 | Neoplasms |
7536929 |
Ras farnesyltransferase inhibitors suppress the phenotype resulting from an activated ras mutation in Caenorhabditis elegans. |
causal interaction
therapeutic application
unassigned |
3
4
0 |
| 2.5.1.21 | Hypertension, Pulmonary |
7542078 |
Effect of limonene and sobrerol on monocrotaline-induced lung alterations and pulmonary hypertension. |
causal interaction
ongoing research
therapeutic application
unassigned |
3
2
4
0 |
